News

Life Sciences Baltics 2014 is the only international forum in the Baltic region for world-class biotechnology, pharma and medical devices experts from all around the world. It provides a unique opportunity to explore the new horizons of partnerships, exchange ideas and seek progress through networking. Discover enormous potential and passion in the field of life sciences in Lithuania and the Baltic region – the gateway to emerging markets.

1.     The only one Life Sciences forum in the Baltic region, reoccurring every two years.

2.     More than 800 key sector players and decision makers from more than 30 countries (including delegations from US, Israel, EU. and CIS), regulatory bodies and government representatives.

3.     Nobel Prize Winner and globally acclaimed speakers.

4.     Learn on EU strategy, directions and funding opportunities.

5.     Discover talent pool and state-of-the-art scientific infrastructure of the Baltic countries.

6.     Focus on networking and establishing partnerships.

7.     Meet (pre)investor-ready startups. 

8.     Multi-modular event: plenary and panel sessions, international exhibition, partnership event, company visits, social networking programme, students conference. 

• Discover state-of-the-art scientific infrastructure and investor-ready startups in the Baltics
• Meet Nobel prize winners, 800 key sector players and decision makers from more than 30 countries
• Learn EU strategic directions and funding opportunities
• Tell the world about your discovery at the international conference, exhibition and networking events. 

Programme and speakers:

At this forum, the world-famous representatives of the sector’s academic institutions and business enterprises will share their ideas about regenerative medicine, clinical studies, commercialisation as well as investment attraction. At the forum insights and experience in the field will be shared by representatives of Pfizer, General Electric Healthcare Sciences, the Japanese Science and Technology Agency, the European Federation of Pharmaceutical Industries and Associations (EFPIA), Israel’s Weizmann Institute, and other institutions and companies of this viable sector.   

The main speaker - Nobel Prize winner Professor Kary B. Mullis

Other speakers and participants:

Richard Bergstrom – Director of the European Federation of Pharmaceutical Industries and Associations

Ruxandra Draghia-Akli  - Director, Directorate-General for Research and Innovation, European Commission

Dr. Tony Hunter -  Professor in the Molecular and Cell Biology Laboratory and Director of the Salk Institute Cancer Center; was nominated to the Nobel Prize.

Prof. Karin Moelling  - Professor, famous Cancer and HIV scientist

Dr. Stephen Minger - Chief Scientist, GE Healthcare Life Sciences  (General Electrics grupės dalis)

“The forum is a meeting place for top tier managers and scientists from sector’s leading countries – the USA, Israel, Switzerland, Japan and Germany. I am happy that the Baltic scientists and entrepreneurs engaged in the life sciences sector are valued as desirable partners in the implementation of international programmes and projects such as FP7, Horizon 2020. Lithuanians have gained a reputation as reliable providers of quality scientific research and services in the field of life sciences. This is highly important as trustworthiness is the key element of this sector, giving companies a competitive advantage,” pointed out Prime Minister Algirdas Butkevičius.

For more information:  http://www.lsb2014.com/en/about-lsb/about-lsb-forum/ .

Programme:  http://www.lsb2014.com/en/programme/programme/?programme=p2